Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Your Valuation
Community
/
United States
/
Pharmaceuticals & Biotech
Create a narrative
Pacific Biosciences of California Community
NasdaqGS:PACB Community
2
Narratives
written by author
0
Comments
on narratives written by author
45
Fair Values set
on narratives written by author
Community Investing Ideas
Pacific Biosciences of California
Popular
Undervalued
Overvalued
Pacific Biosciences of California
AN
AnalystHighTarget
Consensus Narrative from 8 Analysts
Vega Shipments And Multi-Omics Trends Will Fuel Genomics Breakthroughs
Key Takeaways Accelerated adoption of new platforms and technologies is expanding PacBio's user base, international reach, and revenue diversification opportunities. Advances in product offerings and strategic partnerships are enhancing margins, market positioning, and access to high-growth clinical and precision medicine segments.
View narrative
US$3.00
FV
57.3% undervalued
intrinsic discount
22.00%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
1
users have followed this narrative
New
narrative
Pacific Biosciences of California
AN
AnalystConsensusTarget
Consensus Narrative from 8 Analysts
Clinical Genomics Adoption Will Broaden Precision Medicine Markets
Key Takeaways Advances in clinical genomics and innovative sequencing platforms are expanding market reach, driving recurring revenue growth and improving margins. Operational improvements and broader healthcare adoption are lowering barriers, enhancing profitability, and supporting long-term growth despite near-term challenges.
View narrative
US$2.06
FV
37.7% undervalued
intrinsic discount
16.29%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
26
users have followed this narrative
6 days ago
author updated this narrative
Your Valuation for
PACB
PACB
Pacific Biosciences of California
Your Fair Value
US$
Current Price
US$1.28
26.0% undervalued
intrinsic discount
Growth estimate over
Annual revenue growth rate
5 Years
time period
%/yr
Decrease
Increase
Past
Future
-526m
306m
2015
2018
2021
2024
2025
2027
2030
Revenue US$306.5m
Earnings US$39.2m
Advanced
Set Fair Value